SHENYANG SUNSHINE PHARMACEUTICAL CO LTD has a total of 14 patent applications. Its first patent ever was published in 2007. It filed its patents most often in China, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are SHANGHAI LONGWOOD BIOPHARMACEUTICALS CO LTD, DART NEUROSCIENCE (CAYMAN) LTD and INFINITY DISCOVERY INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | United States | 3 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Jiao Lingling | 11 |
#2 | Zhou Yunlong | 11 |
#3 | Guo Ming | 11 |
#4 | Jing Yu | 11 |
#5 | Cai Suixiong | 11 |
#6 | Wang Guangfeng | 9 |
#7 | Min Ping | 9 |
#8 | Lou Jing | 3 |
#9 | Hou Xufeng | 3 |
#10 | Cai Minmin | 2 |
Publication | Filing date | Title |
---|---|---|
WO2017161555A1 | Intermediate for compounding 5-hydroxyl-1,7-naphthyridine compound substituted by aryl or heteroaryl, and preparation method therefor | |
US2018117021A1 | Compound of 3-hydroxyl pyridine, preparation method thereof and pharmaceutical use thereof | |
EP3275881A1 | Compound of 5-hydroxyl-1,7-naphthyridine substituted by aryloxy or heterooxy, preparation method thereof and pharmaceutical use thereof | |
US2018118738A1 | Compound of 5-hydroxyl-1,7-naphthyridine substituted by aryl or heteroaryl, preparation method thereof and pharmaceutical use thereof | |
CN102349996A | Human papilloma virus pharmaceutical composition and application thereof | |
CN103113464A | Natural human erythropoietin analogue | |
CN101337988A | New erythrocyte-stimulating factor analogues |